LP16176-7LORazepamActive
Descriptions
LP16176-7 LORazepam
Lorazepam (marketed under the brand names Ativan®, Temesta®, Tavor®) is a drug which is a benzodiazepine derivative. Pharmacologically, it is classified as a sedative -hypnotic, anxiolytic and anticonvulsant. Lorazepam reduces anxiety, interferes with new memory formation, reduces agitation, induces sleep, treats seizures, treats nausea and vomiting, and relaxes muscles. Lorazepam is used for the short-term treatment of anxiety, insomnia, acute seizures including status epilepticus, and sedation of hospitalized patients, as well as sedation of aggressive patients. Due to tolerance and dependence, lorazepam is recommended for short-term use, up to two to four weeks only. Among benzodiazepines, lorazepam has possible physical addiction potential. Lorazepam also has misuse potential; the main types of misuse are for recreational purposes.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Lorazepam (Wikipedia)
LP16176-7 LORazepam
A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Name
- LORazepam
- Type
- Component
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- LORazepam
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16176-7
Language Variants Get Info
- zh-CNChinese (China)
- 氯羟安定
Synonyms: 劳拉西泮;氯羟去甲安定 - nl-NLDutch (Netherlands)
- lorazepam
- et-EEEstonian (Estonia)
- Lorasepaam
- fr-BEFrench (Belgium)
- Lorazépam
- fr-CAFrench (Canada)
- Lorazépam
- it-ITItalian (Italy)
- Lorazepam
- ru-RURussian (Russian Federation)
- Лоразепам
- es-ESSpanish (Spain)
- Lorazepam
Synonyms: Ativan - tr-TRTurkish (Turkey)
- Lorazepam
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright